Download - Hepatic Cancer
-
7/28/2019 Hepatic Cancer
1/13
Cancer in Children
HEPATIC TUMOURS
-
7/28/2019 Hepatic Cancer
2/13
Introduction
Child presents with mass in the quadrant of theabdomen , the differential diagnosis includehepatic malignancy must be distinguished
from: benign hepatic tumor, non neoplastichepatomegali,neuroblastoma, nephroblastoma. Two-third of hepatic neoplasm were malignant
(50-60%) and approximately 90% were:epithelial tumors, hepatoblastoma or
hepatocellular carcinoma. Ratio hepatoblastoma to hepato cellular
carcinoma is 1,8 :1 and incidence ofhepatoblastoma 5-6 time higher thanhepatocellular carcinoma.
-
7/28/2019 Hepatic Cancer
3/13
HEPATOBLASTOMA Hepatoblastoma is the most common malignant
hepatic tumor in children, hepatocellularcarcinoma is more common due to endemichepatitis B infection with its vertical
transmission. The incidence in children under 15 years is less
than 1 per 1.000.000 in North America, in Japanto be higher than Western.
Ratio males and female= 1,2 : 1
More than 80% tumor are seen in child 3 yearsage or younger and 45% of patient arediagnosed during first years of life.
-
7/28/2019 Hepatic Cancer
4/13
Genetic and biology
Hepatoblastoma may occur in association with
variety of - congenital anomalies,disorder, and
enviromental factors.
Beckwith-Wiedemann syndrome and hemihypertrophy , rhabdomyosarcoma, and
adrenocortical tumors an increase risk of thistumor.
Abnormalities of the short arm chromosome 11have been shown and loss of heterozygosity of
11 p15 has frequently been observed. Cytogenetic of tumor cell have shown that
trisomy of chromosome 2 and 20 is frequentlyobserved.
DNA content analyses have shown patient with
diploid have better prognosis than aneuploid
-
7/28/2019 Hepatic Cancer
5/13
Pathology
Hepatoblastoma is usually soliter and 20% oftumor extend multifocally or infiltrate diffuselyinto the liver.
Microscopically : pure epithelial hepatoblastomais distinguished from mixed hepatoblastoma,which contains mesenchymal tissue in additionto epithelial elements.
Epithelial component exhibit a range of
differentiation represented by fetal, embryonaland anaplastic cells.
-
7/28/2019 Hepatic Cancer
6/13
Diagnosis Anorexia; weight loss, anemia.
Alpha-fetoprotein (AFP) is raised above theupper limited more than 98% patient.
Thrombocytosis; normochromic normocytic
anemia is usually.
Hypercholesterolaemia or osteoporosis and latermay be complicated by pathological fracture.
Imaging study: plain radiography, USG; CT; MRI
Bone scan should be done to investigatemetastatic spread. Bone marrow aspirates areunnecessary.
-
7/28/2019 Hepatic Cancer
7/13
Staging
Pediatric Oncology Group USA/Children CancerGroup:
Stage I: tumor is define as a tumor resectedcompletely at initial laparatomy.
Stage II: as a tumor with microscopic residue
Stage III: as a tumor with gross residual tumor.
Stage IV: as a distant matastases
-
7/28/2019 Hepatic Cancer
8/13
Treatment
1. Surgical treatment :
Complete surgical resection most effective treatment, butless than 50% tumor are resectable at time of diagnosis.
The tumor is deemed resectable if it is localized in one ortwo segment of the liver. Segmentectomy or standardlobectomy.
2. Chemotherapy ( see protocol)
Iphosphamide: 1.5/m2 for 3 days
Cisplatin 20mg/m2daily dose
Adriamycin 20 mg/m2
-
7/28/2019 Hepatic Cancer
9/13
Hepatocellular carcinoma Hepatocellular carcinoa accounts for 10-30% of
primary, malignant, hepatic tumors in Westernand Japan, but is more prevalent andoutnumbers hepatoblastoma in areas wherehepatitis B virus infection is endemic.
Tumor usually occurs in children older than 5years. Male dominant than female.
Hepatitis B virus infection is causally withdevelopment of hepatocellular carcinoma.
Tumor associated with number of underlyingdisease: tyrosinemia, biliary atresia, idiopaticneonatal hepatitis, alpha 1- trypsin deficiency
-
7/28/2019 Hepatic Cancer
10/13
Pathology
The gross and microscopic feature ofhepatocellular carcinoma is similar in childrenand adult, except for lower incidence of
underlying cirrhosis. Children 5-30% cirrhosis ispresent, in adult 50-85%.
Tumor as multiple nodulus or diffuse infiltratingmass involving both lobes of the liver.
The cut surface is often bile stained, andhemorrhagic and necrosis are more often thanhepatoblastoma.
-
7/28/2019 Hepatic Cancer
11/13
Diagnosis Sign: abdominal pain; a palpable mass
and hepatomegali is frequently.
Fever, weight loss and jaundiceoccasionally observed. Shock and intraabdominal bleeding may be initialmanifestation of tumor rupture.
Anemia and hiperbilirubinemia, serumAFP is high in 50-80% of patients.Possible presence of hepatitis B infection
Imaging study: USG,CT,MRI
Metastases spread is to lungs, regional
lymph nodes and bone (rare)
-
7/28/2019 Hepatic Cancer
12/13
Treatment
Complete resection is the basis of successfultreatment, but resectability of the tumor is 10-20%. Most children die within 12 months of
diagnosis. Intensive chemotherapy : the result so far have
generally been dismal.
Combination of : iphosphamid ; cisplatin and
adriamycin. Total hepatectomy and orthotopic liver
transplantation appears to be effective.
-
7/28/2019 Hepatic Cancer
13/13